微信扫一扫
实时资讯全掌握
|
When would the asset-based approach result in a higher valuation than its going concern value, in the case of private company valuation? A. When valuing pharmaceutical firms. B. When valuing biotech firms. C. If the firm has minimal profits and poor prospects. |